Nycomed Bookmark and Share

ArticleDateSource
Medicis, Nycomed Settle Vanos Patent Dispute--Pharmaceutical - Moreover
Ex-Nycomed chief to take chairman's seat at LundbeckFebruary 20, 2013FiercePharma
Nycomed Deal Shows How Small PE Firms Can Reap Billions October 04, 2012BioSpace
EU Regulators Drop Antitrust Probe Into AstraZeneca PLC, Nycomed March 01, 2012BioSpace
EC antitrust squad drops AZ-Nycomed probeMarch 01, 2012FiercePharma
Takeda consumption of Nycomed to cost 2,800 jobsJanuary 18, 2012FiercePharma Manufacturing
Takeda plans 2,800 job cuts after Nycomed dealJanuary 18, 2012Pharmaceutical - Moreover
Takeda Restructures After Nycomed AcquisitionJanuary 18, 2012Contract Pharma
Takeda blasted by strong yen as Nycomed costs eat into profit outlookNovember 04, 2011Pharmaceutical - Moreover
Takeda Slashes Profit Forecast by 32% on Nycomed Takeover CostsNovember 04, 2011Pharmaceutical - Moreover
Takeda's plate full with Nycomed integrationOctober 17, 2011FiercePharma
Nycomed: Takeda Appoints Jostein Davidsen Head of Emerging MarketsOctober 17, 2011Pharmaceutical - Moreover
European CLOs will benefit from Nycomed prepayment, says Moody'sOctober 10, 2011Pharmaceutical - Moreover
Avista Capital takes on ex Nycomed CEOOctober 07, 2011Pharmaceutical - Moreover
Takeda Rating Cut to Aa3 by Moody’s on Nycomed AcquisitionOctober 03, 2011Pharmaceutical - Moreover
Takeda completes Nycomed acquisition, installs new chief executiveOctober 03, 2011Pharmaceutical - Moreover
Takeda completes Nycomed dealOctober 03, 2011Pharmaceutical - Moreover
Takeda finalizes 9.6 billion-euro buy of Nycomed and names new CEOOctober 03, 2011Pharmaceutical - Moreover
TEXT-S&P Takeda Pharmaceutical downgraded to 'AA-' On Nycomed DealOctober 03, 2011Pharmaceutical - Moreover
Takeda closes Nycomed buy, moves to 12th in pharma sales tableOctober 03, 2011Pharmaceutical - Moreover
Takeda completes acquisition and names new CEO of Nycomed Friday, 30 September 2011 Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S ("Nycomed") for 9.6 billion Euro on a cash-free, debOctober 02, 2011Pharmaceutical - Moreover
Nordic Capital Completes €9.6bn Nycomed DealSeptember 30, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. Completes Euro 9.6 Billion Acquisition and Names New CEO of Nycomed September 30, 2011BioSpace
Takeda Completes Nycomed Acquisition, Appoints CEOSeptember 30, 2011Contract Pharma
Takeda Completes Acquisition and Names New CEO of Nycomed (PRN)September 30, 2011Pharmaceutical - Moreover
Nordic Capital Closes EUR9.6 Billion Nycomed TransactionSeptember 30, 2011Pharmaceutical - Moreover
Nycomed snaps up Asian rights to Almirall medSeptember 29, 2011FiercePharma
Japan Pharmaceuticals and Healthcare Report Q4 2011 - In May 2011, Takeda Acquired Privately-Held Swiss Pharmaceutical Company Nycomed for US$13.7bnSeptember 27, 2011Pharmaceutical - Moreover
Research and Markets: Japan Pharmaceuticals and Healthcare Report Q4 2011 - In May 2011, Takeda Acquired Privately-Held Swiss Pharmaceutical Company Nycomed for US$13.7bnSeptember 16, 2011Pharma News - Business Wire
NICE asks for more data on Merck/Nycomed COPD drugSeptember 09, 2011FiercePharma
National Institute for Clinical Excellence (NICE) Questions Merck & Co., Inc., Nycomed COPD Drug September 09, 2011BioSpace
Medicis, Nycomed Settle Vanos Patent DisputeAugust 18, 2011Pharmaceutical - Moreover
Nycomed reports double-digit growth across emerging markets in second quarter 2011August 17, 2011Pharmaceutical - Moreover
Orion Corporation, Nycomed Sign Deal for Easyhaler August 05, 2011BioSpace
Orion Corporation, Nycomed Sign Deal for Easyhaler August 05, 2011BioSpace
Takeda acquires Nycomed for $13.7 billionAugust 03, 2011Pharmaceutical - Moreover
New Nycomed US chief aims to grow by M&AAugust 02, 2011FiercePharma
Takeda acquisition of Nycomed cleared in EUAugust 02, 2011Pharmaceutical - Moreover
UPDATE: Nycomed US King Pharma Executives As Senior ExecutivesAugust 01, 2011Pharmaceutical - Moreover
Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer - Company Also Adds Jeff Bailey to Newly Created Position of COO and John Golubieski as CFO - - Appointment Underscores Focus on Growth as an Independent Entity -August 01, 2011Pharmaceutical - Moreover
<b>Nycomed US Inc.</b> Names <b>Brian A. Markison</b> as Chief Executive Officer August 01, 2011BioSpace
Nycomed US Inc. Names Brian A. Markison as Chief Executive OfficerAugust 01, 2011Biotech News - PR Newswire
Nycomed reports increased Q1 earningsMay 26, 2011Pharmaceutical - Moreover
Nycomed US to Become Independent Following Takeda TakeoverMay 23, 2011Pharmaceutical - Moreover
Takeda to buy Nycomed for $13.7 bnMay 21, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical to acquire Nycomed International Deal In BriefMay 21, 2011Pharmaceutical - Moreover
Takeda to Buy Nycomed for $13.7 BillionMay 21, 2011Pharmaceutical - Moreover
Acquisition of Nycomed A/S by Takeda Pharmaceutical Company Limited Call - Takeda Pharmaceutical Co., Ltd. - Earnings TranscriptMay 21, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Nails Nycomed Buyout for $May 20, 2011Pharmaceutical - Moreover
Takeda Expands Global Reach with $13.7 Billion Nycomed BuyMay 20, 2011Burrill Report
Takeda Pharmaceutical Co. Ltd., Nycomed Agitating Investment Too Familiar With 40% Loss: Real M&A May 20, 2011BioSpace
Japanese drugmaker Takeda to buy Nycomed as part of expansion plansMay 20, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Nails Nycomed Buyout for $13.7 Billion, Skin Unit to Spin OffMay 19, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical to buy out Swiss-firm Nycomed for â¬9.6 billionMay 19, 2011Pharmaceutical - Moreover
Takeda buying Nycomed for $13.6 billionMay 19, 2011Pharmaceutical - Moreover
Nordic Capital et al. sell Nycomed for €9.6bnMay 19, 2011Pharmaceutical - Moreover
Takeda Goes Global With $13.7B Nycomed DealMay 19, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. Nails Nycomed Buyout for $13.7 Billion, Skin Unit to Spin Off May 19, 2011BioSpace
Takeda to Buy Nycomed for $9.1 Billion to Fill Sales GapMay 19, 2011Pharmaceutical - Moreover
Japanese Takeda to buy Swiss Nycomed for EUR 9.6bnMay 19, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. Wraps Up Nycomed for $13.7 Billion, Skin Unit to Spin Off May 19, 2011BioSpace
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) to Acquire Nycomed for $13.7 Billion, Skin Unit to Spin OffMay 19, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. to Acquire Nycomed for $13.7 Billion, Skin Unit to Spin Off May 19, 2011BioSpace
Takeda snaps up Nycomed in $13.6B dealMay 19, 2011FiercePharma
Takeda Inks $13.6B Deal to Buy Nycomed to Bolster Footprint in Europe and Emerging MarketsMay 19, 2011Inside Industry - Gen
Takeda to Buy Nycomed for $13.7 Billion to Fill Sales GapMay 19, 2011Pharmaceutical - Moreover
Nordic Capital sells Nycomed for €9.6bnMay 19, 2011Pharmaceutical - Moreover
Takeda takes Nycomed in €9.6 billion dealMay 19, 2011Pharmaceutical - Moreover
Takeda Inks $13.6B Deal to Buy Nycomed to Expand Presence in Europe and Emerging MarketsMay 19, 2011Inside Industry - Gen
Takeda to Purchase Nycomed for E9.6 billionMay 19, 2011Pharmaceutical - Moreover
Takeda to Acquire Nycomed - Transaction will Transform Takeda's Global BusinessMay 19, 2011Pharmaceutical - Moreover
Takeda acquires Nycomed for USD9.1bMay 19, 2011Pharmaceutical - Moreover
Takeda wraps $13.7B Nycomed buyout, skin unit spins off May 19, 2011FierceBiotech
Takeda to Buy Nycomed for $13.6B to Expand Presence in Europe and Emerging MarketsMay 19, 2011Inside Industry - Gen
Takeda Pharmaceutical To Buy Swiss Rival Nycomed For EUR9.6 BillionMay 19, 2011Pharmaceutical - Moreover
Japan's Takeda Pharmaceutical buys Swiss drugmaker Nycomed to expand into emerging marketsMay 19, 2011Pharmaceutical - Moreover
Japan's Takeda to buy Swiss firm Nycomed for $13.6 billionMay 19, 2011Pharmaceutical - Moreover
Takeda to buy Swiss drugmaker Nycomed for $13.6 billionMay 19, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical To Buy Swiss Rival Nycomed For EUR9.6bnMay 19, 2011Pharmaceutical - Moreover
15:49 - Takeda Pharmaceutical To Buy Swiss Rival Nycomed For EUR9.6bnMay 19, 2011Pharmaceutical - Moreover
BRIEF-Nycomed US to operate as independent corporationMay 19, 2011Pharmaceutical - Moreover
Japan's Takeda buying Nycomed for $13.6 billionMay 19, 2011Pharmaceutical - Moreover
Nycomed's US Dermatology Business to Become an Independent Entity Following Nycomed's Acquisition by TakedaMay 19, 2011Medical Pharma - PR Newswire
Is Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Finally Set to Buy Nycomed for $May 19, 2011Pharmaceutical - Moreover
Is Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Finally Set to Buy Nycomed for $12 Billion? - Deal to be Formally Announced TodayMay 18, 2011Pharmaceutical - Moreover
Is Takeda Pharmaceutical Co. Ltd. Finally Set to Buy Nycomed for $12 Billion? - Deal to be Formally Announced Today May 18, 2011BioSpace
Nikkei says Nycomed buyout imminent; Takeda says noMay 18, 2011FiercePharma
Deal or no deal? Takeda scuttles report on imminent $13B pact for Nycomed May 18, 2011FierceBiotech
Takeda Pharmaceutical (TKPHF.PK), Asia's top drug maker, is reportedly set to announce the purchase of closely-held Swiss rival Nycomed as soon as this morning. The price tag is expected to be around ¥1T ($12B). (previously)May 18, 2011Pharmaceutical - Moreover
Takeda to reveal purchase of Nycomed WednesdayMay 18, 2011Pharmaceutical - Moreover
Takeda expected to buy Nycomed for $12.3B: reportMay 18, 2011Pharmaceutical - Moreover
BRIEF-Takeda to reach agreement on Wednesday to acquire Nycomed for about JPY 1 trln - NikkeiMay 17, 2011Pharmaceutical - Moreover
Takeda denies Nycomed takeover talksMay 16, 2011Pharmaceutical - Moreover
Takeda deny Nycomed takeover talksMay 16, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. Denies Reaching Agreement to Buy Nycomed May 13, 2011BioSpace
Takeda: No deal has been struck for Nycomed May 13, 2011FierceBiotech
Nycomed ‘attracts a Japanese suitor’May 13, 2011Pharmaceutical - Moreover
Takeda: No truth to reports on Nycomed dealMay 13, 2011Pharmaceutical - Moreover
Japan's Takeda Pharma in $12 billion to buy Swiss rival Nycomed: reportMay 13, 2011Pharmaceutical - Moreover
Switzerland's Nycomed silent on reported Takeda bidMay 12, 2011Pharmaceutical - Moreover
Takeda in Talks to Buy Nycomed for $14 Billion: Report - CNBCMay 12, 2011Pharmaceutical - Moreover
Nordic Capital’s Nycomed in possible €8bn saleMay 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Discusses Nycomed TakeoverMay 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical In Advanced Talks To Buy Swiss Firm Nycomed - SourcesMay 12, 2011Pharmaceutical - Moreover
Takeda in Talks to Buy Nycomed for Up to $14 BillionMay 12, 2011Pharmaceutical - Moreover
Report: Takeda to acquire Nycomed in $12 billion dealMay 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Said to Be in Talks to Buy Nycomed for up to $14 BillionMay 12, 2011Pharmaceutical - Moreover
Nycomed targeted for takeover by Takeda; reportsMay 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Said to Be in Talks to Buy Nycomed for up to $May 12, 2011Biotechnology - Moreover
Takeda in talks to buy Nycomed for up to $14BMay 12, 2011FiercePharma
Takeda offers $12 bln for Swiss drugs firm Nycomed - sourcesMay 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. Said to Be in Talks to Buy Nycomed for up to $14 Billion May 12, 2011BioSpace
Takeda seeks global reach with $12 billion Nycomed bidMay 12, 2011Health News - CNBC
Takeda eyes $14B Nycomed acquisitionMay 12, 2011Health News - BizJournals.com
Takeda pursues Nycomed with $12B-$14B buyout offerMay 12, 2011FierceBiotech
Takeda offers $12 billion for drugs firm Nycomed: sourcesMay 12, 2011Health News - CNBC
Japan's Takeda to pay $12B for Nycomed: reportMay 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical (TKPHF.PK), Asia's top drug maker, is reportedly in talks to buy closely-held Swiss rival Nycomed. Sources say Takeda and Nycomed have discussed an offer above ;8B ($11.4B) but that Nycomed may hold out for more than ;10B.May 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical In Advanced Talks To Buy Swiss Firm Nycomed -SourcesMay 12, 2011Pharmaceutical - Moreover
Japan's Takeda to buy drugmaker Nycomed for $12 bnMay 12, 2011Pharmaceutical - Moreover
Takeda eyes $14.2 billion Nycomed deal: reportMay 12, 2011Pharmaceutical - Moreover
Takeda to buy Swiss firm Nycomed: reportMay 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical: Decline To Comment On Nycomed ReportMay 12, 2011Pharmaceutical - Moreover
BRIEF-Takeda Pharmaceutical said to be in talks to buy Nycomed - BloombergMay 12, 2011Pharmaceutical - Moreover
Takeda in talks to buy Nycomed in $14.2 billion deal: reportMay 12, 2011Pharmaceutical - Moreover
UPDATE 1-Takeda in talks to buy Nycomed in $14.2 bln deal-reportMay 12, 2011Pharmaceutical - Moreover
Nycomed Expands In Turkey, Despite Tough Pharma EnvironmentApril 14, 2011Pharmaceutical - Moreover
Nycomed acquires distribution rights to product portfolio in TurkeyApril 13, 2011Pharmaceutical - Moreover
Nycomed submits teduglutide MAA to EMA for SBS treatmentMarch 29, 2011Pharmaceutical - Moreover
Nycomed Faces IP Suit Over Solaraze GelMarch 18, 2011Pharmaceutical - Moreover
Nycomed eyes emerging markets boost to 60% of salesMarch 04, 2011FiercePharma
Nycomed results hit by patent issuesMarch 03, 2011Pharmaceutical - Moreover
FDA Approves Nycomed and Forest’s Daliresp for Reducing COPD ExacerbationsMarch 01, 2011Inside Industry - Gen
Forest Laboratories, Inc., Nycomed Get Approval for Lung Drug, Roflumilast March 01, 2011BioSpace
Forest, Nycomed win narrow FDA approval on new COPD drugMarch 01, 2011FierceBiotech
FDA Approves Nycomed and Partner Forest’s Daliresp for Reducing COPD ExacerbationsMarch 01, 2011Inside Industry - Gen
Forest, Nycomed get approval for lung drugMarch 01, 2011Health News - CNBC
DURECT Corporation Reports Data From European Phase IIb Shoulder Study of POSIDUR(TM) (SABER(TM)-Bupivacaine) and Amendment of the Nycomed Agreement February 09, 2011BioSpace - Breaking News
DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR™ (SABER™-Bupivacaine) and Amendment of the Nycomed AgreementFebruary 09, 2011Clinical Trials - PR Newswire
Nycomed to Acquire FarmacolFebruary 07, 2011Pharmaceutical - Moreover
Swiss Nycomed to acquire Colombian Laboratorios FarmacolFebruary 04, 2011Pharmaceutical - Moreover
Nycomed moves into Colombia with Farmacol acquisitionFebruary 04, 2011Pharmaceutical - Moreover
Nycomed to Acquire Colombia's February 04, 2011BioSpace
Nycomed To Acquire Colombian Company FarmacolFebruary 04, 2011Health News - Fox Business
Nycomed S.C.A SICAR: PharmaVitae ProfileJanuary 20, 2011Pharmaceutical - Moreover
Nycomed S.C.A SICAR: PharmaVitae Profile - companiesandmarkets.com adds new reportJanuary 14, 2011Pharmaceutical - Moreover
Eurand Enters Agreement With Nycomed for ZENPEP in Russia-CISJanuary 13, 2011Pharmaceutical - Moreover
Eurand and Nycomed Sign Agreement for ZENPEP® in Russia-CISJanuary 13, 2011Pharmaceutical - Moreover
Eurand Announces Agreement With Nycomed for ZENPEP® in Russia-CISJanuary 13, 2011Pharmaceutical - Moreover
Nycomed Announces Agreement with Eurand for ZENPEP® in Russia-CISJanuary 13, 2011Pharmaceutical - Moreover
Nycomed Announces Agreement with Eurand for Zenpep in Russia-CISJanuary 12, 2011Pharmaceutical - Moreover
Eurand, Nycomed reach marketing deal for ZenpepJanuary 12, 2011Health News - CNBC
Eurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CISJanuary 12, 2011Marketwire - Pharma and Biotech
Nycomed Acquires Majority Stake in Guang...January 07, 2011Pharmaceutical - Moreover
Nycomed Calls On WilmerHale In Vanos Patent SuitJanuary 05, 2011Pharmaceutical - Moreover
Medicis Hits Nycomed Unit With 3rd Vanos Patent SuitDecember 17, 2010Pharmaceutical - Moreover
Nycomed's Q3 undermined by pantoprazole declineNovember 11, 2010Pharmaceutical - Moreover
Joseph J. LaRosa Joins Nycomed US Inc.November 10, 2010Pharma News - PR Newswire
Nycomed CEO: Drug Sector Consolidation To ContinueNovember 10, 2010Health News - Fox Business
Nycomed to acquire majority stake in TechpoolNovember 05, 2010Pharmaceutical - Moreover
Nycomed to acquire majority in Chinese firmNovember 03, 2010Pharmaceutical - Moreover
Nycomed expands China presence with Techpool stakeNovember 02, 2010Pharmaceutical - Moreover
Nycomed to acquire majority stake in Chinese bio-pharma company TechpoolNovember 02, 2010Pharmaceutical - Moreover
Nycomed Buys Major Stake In Chinese Firm, Guangdong Techpool Bio-Pharma For $2November 01, 2010Pharmaceutical - Moreover
Nycomed Buys Major Stake In Chinese Firm, For $210 Million November 01, 2010BioSpace
Nycomed grabs $210M stake in China's TechpoolNovember 01, 2010FiercePharma
Nycomed Takes Majority Stake in Chinese Pharma Firm Techpool Bio-PharmaNovember 01, 2010Inside Industry - Gen
Nycomed to Accelerate Expansion in China Through Acquisition of Majority Stake in Guangdong Techpool Bio-PharmaNovember 01, 2010Biotech News - PR Newswire
Zydus Nycomed commissions the newly expanded API manufacturing facility at Navi MumbaiSeptember 30, 2010Pharma News - PharmiWeb
CORRECTED - CORRECTED-Nycomed seeks damages from Sun Pharma, TevaSeptember 29, 2010Pharmaceutical - Moreover
Nycomed JV Opens API Facility in IndiaSeptember 29, 2010Pharmaceutical - Moreover
Nycomed resolute on pursuing damages from Teva, Sun over generic ProtonixSeptember 29, 2010Pharmaceutical - Moreover
Samenvatting: EffRx en Nycomed maken eerste Europese aanvraag voor marktgoedkeuring voor medicijn tegen osteoporose voor meer gemak bij patiëntenSeptember 21, 2010Pharma News - Business Wire
EffRx et Nycomed annoncent le dépôt de la première demande européenne d’approbation de commercialisation d’un médicament contre l’ostéoporose visant à un meilleur confort pour les patientsSeptember 21, 2010Pharma News - Business Wire
EffRx y Nycomed anuncian primera presentación europea para la aprobación para la comercialización de un fármaco contra la osteoporosis para mayor comodidad para los pacientesSeptember 21, 2010Pharma News - Business Wire
EffRx e Nycomed anunciam a primeira petição europeia para a aprovação da comercialização de um medicamento para o tratamento da osteoporose com um sistema de administração mais conveniente para o pacienteSeptember 21, 2010Pharma News - Business Wire
EffRx und Nycomed geben die Einreichung des ersten Antrags auf Marktzulassung eines Osteoporosemittels für mehr Patientenkomfort in Europa bekanntSeptember 21, 2010Pharma News - Business Wire
Riassunto: EffRx e Nycomed annunciano di aver presentato la prima richiesta di autorizzazione alla vendita a livello europeo di un farmaco contro l'osteoporosi che mira alla maggiore comodità dei pazientiSeptember 21, 2010Pharma News - Business Wire
EffRx and Nycomed Announces First European Filing for Marketing Approval of Osteoporosis Drug Targeting Increased Convenience for PatientsSeptember 21, 2010Pharma News - Business Wire
BTG to Facilitate Return of U.S. Drug Rights from Nycomed with up to $16.6MAugust 31, 2010Inside Industry - Gen
BTG plc Signs $16.6 Mln Deal To Sell Nycomed's Antivenom Drugs August 31, 2010BioSpace
BTG to Facilitate Return of U.S. Drug Rights from Nycomed with up to $16.6M PaymentAugust 31, 2010Inside Industry - Gen
Research and Markets: Nycomed S.C.A. SICAR: PharmaVitae ProfileAugust 19, 2010Pharma News - Business Wire
Jeffrey Wasserstein Joins Nycomed US Inc.August 05, 2010Pharma News - PR Newswire
Nycomed's US Patent for Pro...July 25, 2010Pharmaceutical - Moreover
Nycomed's U.S. Protonix Patent Upheld in Court (PFE)July 19, 2010Pharmaceutical - Moreover
Nycomed US names new CEOJuly 19, 2010FierceBiotech
<b>Steve Andrzejewski</b> Joins <b>Nycomed US Inc.</b> as New CEO July 19, 2010BioSpace - Breaking News
U.S. District Court upholds validity of Nycomed's Protonix patentJuly 19, 2010Pharmaceutical - Moreover
Steve Andrzejewski Joins Nycomed US Inc.July 19, 2010Pharma News - PR Newswire
Nycomed's U.S. Patent for Protonix(R) (pantoprazole) ValidJuly 19, 2010Pharma News - PR Newswire
EU Backs Nycomed's Daxas In Deadly Lung Disease; Drug Approval Could Spur IPO July 06, 2010BioSpace - Breaking News
Nycomed wins EU approval for COPD therapyJuly 06, 2010FierceBiotech
Nycomed: EU Approves Lung Drug Daxas For Use In COPDJuly 06, 2010Pharmaceutical - Moreover
Essen BioScience and Nycomed Announce Ion Channel Drug Discovery CollaborationJune 21, 2010Pharma News - Business Wire
Quintiles Transnational Corp. Hires Nycomed UK Team; Confirms Undisclosed Number of U.S. Workers Laid-Off on MayMay 25, 2010Biotechnology - Moreover
Quintiles Transnational Corp. Hires Nycomed UK Team; Confirms Undisclosed Number of U.S. Workers Laid-Off on May 20 May 24, 2010BioSpace
AUSTRALIA and Israel-based Immuron has announced it intends to collaborate with unlisted pharmaceutical company Nycomed to develop an influenza prevention product.May 22, 2010Pharmaceutical - Moreover
Nycomed faces patent suit from Medicis regarding generic VanosMay 21, 2010Pharmaceutical - Moreover
Quintiles Acquires Nycomed Team May 20, 2010Contract Pharma
Forest Laboratories, Inc. and Nycomed Receive Complete Response Letter for Roflumilast; FDA Requests More Information May 18, 2010BioSpace - Breaking News
Forest Laboratories and Nycomed Receive Complete Response Letter for RoflumilastMay 17, 2010FDA News - Business Wire
Immunomedics 3Q profit climbs on Nycomed paymentMay 10, 2010Health News - CNBC
Forest and Nycomed to Present Results from Six Roflumilast PostersMay 10, 2010Pharma News - Business Wire
Nycomed to distribute Immuron's TravelanMay 06, 2010Pharmaceutical - Moreover
Nycomed signs agreement with Merck to distribute Daxas (roflumilast) in UKApril 27, 2010Pharmaceutical - Moreover
Nycomed signs agreement with Merck to co-promote Daxas (roflumilast)April 27, 2010Pharmaceutical - Moreover
Court rejects plea against Nycomed's pantoprazole US patentApril 26, 2010Pharmaceutical - Moreover
Merck & Co., Inc. to Help Sell Nycomed Lung Drug Daxas(R) in EU, Canada April 26, 2010BioSpace
Merck & Co., Inc. to Help Sell Nycomed Lung Drug in EU, Canada April 26, 2010BioSpace
Resumen: Nycomed y Merck & Co., Inc., suscriben acuerdos de comercialización para Daxas® en Europa y CanadáApril 26, 2010Pharma News - Business Wire
Samenvatting: Nycomed en Merck & Co., Inc. maken commercialiseringsovereenkomsten bekend betreffende Daxas in Europa en CanadaApril 26, 2010Pharma News - Business Wire
Nycomed scores Merck co-promotion pact for DaxasApril 26, 2010FierceBiotech
Merck, Nycomed To Jointly Market COPD TreatmentApril 26, 2010Health News - Fox Business
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas® in Europe and CanadaApril 26, 2010Pharma News - Business Wire
Nycomed et Merck & Co., Inc. annoncent des accords de commercialisation pour Daxas® en Europe et au CanadaApril 26, 2010Pharma News - Business Wire
Nycomed und Merck & Co. Inc. geben Vereinbarungen für die Vermarktung von Daxas® in Europa und Kanada bekanntApril 26, 2010Pharma News - Business Wire
Riassunto: Nycomed e Merck & Co., Inc., annunciano gli accordi di commercializzazione per Daxas® in Europa e CanadaApril 26, 2010Pharma News - Business Wire
New Jersey District Court jury finds Nycomed's U.S. Patent No. 4,758,579 not invalid: TevaApril 24, 2010Pharmaceutical - Moreover
EU Agency Backs Nycomed's Daxas After U.S. Rebuff April 23, 2010BioSpace
New Market Report Now Available: Nycomed S.C.A. SICAR: PharmaVitae ProfileApril 20, 2010Pharmaceutical - Moreover
<b>Nycomed SCA</b> Still Plans IPO April 12, 2010BioSpace
FDA panel rejects Forest, Nycomed drug Daxas for COPDApril 08, 2010FierceBiotech
US FDA Panel Rejects Forest Laboratories, Inc., Nycomed Lung Drug April 08, 2010BioSpace
US FDA Panel Rejects Forest Laboratories, Inc., Nycomed Lung Drug April 08, 2010BioSpace
US FDA Panel Rejects Forest Laboratories, Inc., Nycomed Lung Drug April 08, 2010BioSpace
Baxter, Nycomed get FDA OK on surgical sealantApril 06, 2010Health News - CNBC
FDA Approves Nycomed's TachoSil PatchApril 06, 2010Health News - Fox Business
Baxter and Nycomed Announce FDA Approval of TachoSil®April 06, 2010FDA News - Business Wire
US FDA Staff Question Forest Laboratories, Inc., Nycomed Lung Drug April 05, 2010BioSpace - Breaking News
Research and Markets: Partnering Agreements with Nycomed 2010March 31, 2010Pharma News - Business Wire
Nycomed S.C.A. SICAR: PharmaVitae Profile - new market analysis releasedMarch 26, 2010Pharmaceutical - Moreover
Nycomed S.C.A. SICAR: PharmaVitae ProfileMarch 25, 2010Pharmaceutical - Moreover
Nycomed Announces First Generic Approval of Imiquimod Cream 5% (Rx), Equivalent to Aldara(R) February 26, 2010BioSpace
Nycomed Invests In New Pharmaceutical Production PlantFebruary 24, 2010Pharmaceutical - Moreover
Durect and Nycomed amend licensing agreementFebruary 23, 2010Pharmaceutical - Moreover
Immunomedics, Inc. Receives First Milestone Payment From Nycomed January 19, 2010BioSpace - Breaking News



View all the latest news